Potentials and restrictions in the use of statutory health insurance data

被引:0
|
作者
Schauer, S. [1 ]
Hartmann, J. [1 ]
Eberhard, S. [2 ]
Krauth, C. [1 ]
Amelung, V. E. [1 ]
机构
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] AOK Niedersachen, Hannover, Germany
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:143 / 144
页数:2
相关论文
共 50 条
  • [1] High use of tramadol in Germany: an analysis of statutory health insurance data
    Tholen, Kathrin
    Hoffmann, Falk
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (09) : 1013 - 1021
  • [2] The Use of Routine Data of Statutory Health Insurance (SHI) in Health Economic Research - Analysis of Applicability
    Reinhold, T.
    Andersohn, F.
    Hessel, F.
    Bruggenjurgen, B.
    Willich, S. N.
    [J]. GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2011, 16 (03): : 153 - 159
  • [3] Use of Secondary Data from the Statutory Health Insurance for an Estimate of the Prevalence of Leg Ulcers
    Spehr, C.
    Schaefer, I
    Kornek, T.
    Siebert, J.
    Augustin, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 124 - 124
  • [4] Use of Health Care Services by People With Mental Illness Secondary Data From Three Statutory Health Insurers and the German Statutory Pension Insurance Scheme
    Gaebel, Wolfgang
    Kowitz, Sandra
    Fritze, Juergen
    Zielasek, Juergen
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2013, 110 (47): : 799 - +
  • [5] Health Reporting with Statutory Health Insurance Routine Data - Possibilities, Limits and Challenges
    Tesch, F.
    Zscheppang, A.
    Schmitt, J.
    [J]. GESUNDHEITSWESEN, 2024, 86 : S55 - S56
  • [6] Detection of drug risks after approval Methods development for the use of routine statutory health insurance data
    Foraita, Ronja
    Dijkstra, Louis
    Falkenberg, Felix
    Garling, Marco
    Linder, Roland
    Pflock, Ren
    Rizkallah, Mariam R.
    Schwaninger, Markus
    Wright, Marvin N.
    Pigeot, Iris
    [J]. BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2018, 61 (09) : 1075 - 1081
  • [7] Epidemiology and Drug Use in Pustulosis palmoplantaris - new Findings from Statutory Health Insurance Data Analyzes
    Augustin, M.
    Hagenstroem, K.
    Reich, K.
    Kirsten, N.
    Petersen, J.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 12 - 12
  • [8] Hidradenitis suppurativa - prevalence analyses of German statutory health insurance data
    Schneider-Burrus, S.
    Lux, G.
    van der Linde, K.
    Barbus, S.
    Huss-Marp, J.
    Tsaousi, A.
    Wasem, J.
    Wolff, B.
    Sabat, R.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (01) : E32 - E35
  • [9] Epidemiology of chronic wounds in Germany: Analysis of statutory health insurance data
    Heyer, Kristina
    Herberger, Katharina
    Protz, Kerstin
    Glaeske, Gerd
    Augustin, Matthias
    [J]. WOUND REPAIR AND REGENERATION, 2016, 24 (02) : 434 - 442
  • [10] Socioeconomic status and health insurance expenditures for children and adolescents with conduct disorder An analysis of statutory health insurance data
    Koenig, Udo
    Heinzel-Gutenbrunner, Monika
    Meinischmidt, Gerhard
    Maier, Werner
    Bachmann, Christian J.
    [J]. BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2019, 62 (09) : 1057 - 1066